UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 24, 2017
MEDIFAST, INC.
(Exact name of registrant as specified in its Charter)
| Delaware | 001-31573 | 13-3714405 | ||
| (State or other jurisdiction | (Commission file number) | (IRS Employer | ||
| of incorporation) | Identification No.) | |||
|
3600 Crondall Lane, Owings Mills, Maryland (Address of Principal Executive Offices) |
21117 (Zip Code) |
Registrant’s telephone number, including area code: (410)-581-8042
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
(b) On March 24, 2017, Medifast, Inc. (the “Company”) was notified by Mr. Brian Kagen, Executive Vice President, Chief Marketing Officer, of his decision to resign his current position, effective on the close of business on April 20, 2017. The Company thanks Mr. Kagen for his service since June 2011 and wishes him well as he leaves to pursue other professional opportunities.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDIFAST, INC. | ||
| By: | /s/ Timothy G. Robinson | |
|
Timothy G. Robinson Chief Financial Officer | ||
| Dated: March 29, 2017 | ||